Literature DB >> 23407467

Incidence and correlates of Chlamydia trachomatis infection in a high-risk cohort of Kenyan women.

Linnet Masese1, Jared M Baeten, Barbra A Richardson, Ruth Deya, Emmanuel Kabare, Elizabeth Bukusi, Grace John-Stewart, Walter Jaoko, R Scott McClelland.   

Abstract

BACKGROUND: In Africa, data on Chlamydia trachomatis infection are scarce because reliable diagnosis is costly and not widely available. Our objective was to evaluate the incidence and correlates of C. trachomatis infection among high-risk Kenyan women.
METHODS: We conducted prospective cohort analyses using data from a cohort of women who reported transactional sex. C. trachomatis testing was performed using the Gen-Probe Aptima GC/CT Detection System. We used Andersen-Gill proportional hazards modeling to evaluate correlates of C. trachomatis.
RESULTS: Between August 2006 and December 2010, 865 women contributed 2011 person-years of observation. Sixty-four women experienced 101 episodes of C. trachomatis infection (incidence rate, 5.0/100 person-years). There was a large difference in incidence by age group: those younger than 25 years had an incidence of 27.6 per 100 person-years (95% confidence interval [CI], 16.3-46.5), those 25 to 34 years old had an incidence of 8.4 per 100 person-years (95% CI, 6.4-11.0), and those 35 years and older had an incidence of 2.6 per 100 person-years (95% CI, 1.8-3.6). In multivariate analyses, younger age (<25 and 25-34 years vs. ≥35 years; hazard ratio [HR], 8.5 [95% CI, 4.1-17.7] and 2.9 [95% CI, 1.7-5.0], respectively), depot medroxyprogesterone acetate use (HR, 1.8; 95% CI, 1.1-3.0), and recent Neisseria gonorrhoeae infection (HR, 3.3; 95% CI, 1.5-7.4) were significantly associated with increased risk of acquiring C. trachomatis infection.
CONCLUSIONS: The high incidence of C. trachomatis among younger high-risk women suggests the need for screening as an important public health intervention for this population.

Entities:  

Mesh:

Year:  2013        PMID: 23407467      PMCID: PMC3831875          DOI: 10.1097/OLQ.0b013e318272fe45

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  30 in total

Review 1.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening.

Authors:  Thomas A Peterman; Lin H Tian; Carol A Metcalf; Catherine L Satterwhite; C Kevin Malotte; Nettie DeAugustine; Sindy M Paul; Helene Cross; Cornelis A Rietmeijer; John M Douglas
Journal:  Ann Intern Med       Date:  2006-10-17       Impact factor: 25.391

3.  Association between participant self-report and biological outcomes used to measure sexual risk behavior in human immunodeficiency virus-1-seropositive female sex workers in Mombasa, Kenya.

Authors:  R Scott McClelland; Barbra A Richardson; George H Wanje; Susan M Graham; Esther Mutunga; Norbert Peshu; James N Kiarie; Ann E Kurth; Walter Jaoko
Journal:  Sex Transm Dis       Date:  2011-05       Impact factor: 2.830

4.  Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.

Authors:  Renee Heffron; Deborah Donnell; Helen Rees; Connie Celum; Nelly Mugo; Edwin Were; Guy de Bruyn; Edith Nakku-Joloba; Kenneth Ngure; James Kiarie; Robert W Coombs; Jared M Baeten
Journal:  Lancet Infect Dis       Date:  2011-10-03       Impact factor: 25.071

5.  Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.

Authors:  Rebecca M Brotman; Mark A Klebanoff; Tonja R Nansel; Kai F Yu; William W Andrews; Jun Zhang; Jane R Schwebke
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

6.  Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections.

Authors:  Rupert Kaul; Nico J Nagelkerke; Joshua Kimani; Elizabeth Ngugi; Job J Bwayo; Kelly S Macdonald; Anu Rebbaprgada; Karolien Fonck; Marleen Temmerman; Allan R Ronald; Stephen Moses
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

7.  Disentangling contributions of reproductive tract infections to HIV acquisition in African Women.

Authors:  Janneke H H M van de Wijgert; Charles S Morrison; Joelle Brown; Cynthia Kwok; Barbara Van Der Pol; Tsungai Chipato; Josaphat K Byamugisha; Nancy Padian; Robert A Salata
Journal:  Sex Transm Dis       Date:  2009-06       Impact factor: 2.830

8.  Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002.

Authors:  S Deblina Datta; Maya Sternberg; Robert E Johnson; Stuart Berman; John R Papp; Geraldine McQuillan; Hillard Weinstock
Journal:  Ann Intern Med       Date:  2007-07-17       Impact factor: 25.391

9.  Chlamydia trachomatis infection as a risk factor for infertility among women in Ghana, West Africa.

Authors:  Jorn Siemer; Oliver Theile; Yaw Larbi; Peter A Fasching; K A Danso; Rolf Kreienberg; Andreas Essig
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

10.  Association of Chlamydia trachomatis serology with tubal infertility in Nigerian women.

Authors:  Lawrence O Omo-Aghoja; Friday E Okonofua; Samson O Onemu; Ulla Larsen; Staffan Bergstrom
Journal:  J Obstet Gynaecol Res       Date:  2007-10       Impact factor: 1.730

View more
  9 in total

1.  Biological and behavioral risks for incident Chlamydia trachomatis infection in a prospective cohort.

Authors:  Loris Y Hwang; Yifei Ma; Anna-Barbara Moscicki
Journal:  Obstet Gynecol       Date:  2014-11       Impact factor: 7.661

2.  Epidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management.

Authors:  Suzanna C Francis; Trong T Ao; Fiona M Vanobberghen; Joseph Chilongani; Ramadhan Hashim; Aura Andreasen; Deborah Watson-Jones; John Changalucha; Saidi Kapiga; Richard J Hayes
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

Review 3.  Providing comprehensive health services for young key populations: needs, barriers and gaps.

Authors:  Sinead Delany-Moretlwe; Frances M Cowan; Joanna Busza; Carolyn Bolton-Moore; Karen Kelley; Lee Fairlie
Journal:  J Int AIDS Soc       Date:  2015-02-26       Impact factor: 5.396

4.  Education, early screening and treatment of STIs could reduce infertility among women in Kenya.

Authors:  S M Musundi
Journal:  Facts Views Vis Obgyn       Date:  2017-06

Review 5.  Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives.

Authors:  Jennifer Deese; Subarna Pradhan; Hannah Goetz; Charles Morrison
Journal:  Open Access J Contracept       Date:  2018-11-12

6.  Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya.

Authors:  Anne Njeri Maina; Joshua Kimani; Omu Anzala
Journal:  BMC Res Notes       Date:  2016-03-29

7.  Comparison of clinical performance of antigen based-enzyme immunoassay (EIA) and major outer membrane protein (MOMP)-PCR for detection of genital Chlamydia trachomatis infection.

Authors:  Mahmoud Nateghi Rostami; Batool Hossein Rashidi; Fatemeh Aghsaghloo; Razieh Nazari
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-06

8.  Gonorrhea, Chlamydia and HIV incidence among female sex workers in Cotonou, Benin: A longitudinal study.

Authors:  Souleymane Diabaté; Annie Chamberland; Nassirou Geraldo; Cécile Tremblay; Michel Alary
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

9.  Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from Uganda.

Authors:  Sergey Yegorov; Ronald M Galiwango; Sara V Good; Juliet Mpendo; Egbert Tannich; Andrea K Boggild; Noah Kiwanuka; Bernard S Bagaya; Rupert Kaul
Journal:  BMC Infect Dis       Date:  2018-11-19       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.